# Progress Note 05 — Focused Visit (Follow-up)

> **SYNTHETIC RECORD, NOT A REAL MEDICAL RECORD**

- Patient: Martin Luther King Jr. (real historical name used in a fictional teaching record)
- Synthetic MRN: HR-ML001-SYN
- Date: 2026-07-14
- Fictional facility: St. Posthumous Health Center
- Fictional author: Cornelius Ashby-Nwankwo, MD
- Calendar frame: modern shifted

- Visit type: Focused Visit (Follow-up)

## Chief complaint

Fourteen-week review: mood, sleep, varenicline, blood pressure and the work plan. **S**

## History of present illness

Dr. King returns six weeks after his eight-week review, just back from a two-week break with his family, the first he has taken in years. He had a video review with Dr. Lindqvist-Bankole last month, who agreed with the plan. His mood is clearly better; he enjoys reading and preaching again and sleeps about six and a half hours. He had one lapse in June, smoking three cigarettes late one night after a threatening call, and has not smoked since. He finishes twelve weeks of varenicline in about four weeks. Home readings over the past week averaged 132/84. He walks most mornings when he is at home and has cut back on fried food. He has no thoughts of harming himself. **S**

| Element | Detail |
|---|---|
| Break | Two weeks away; first in years |
| Mood | Better; PHQ-9 8 |
| Smoking | One lapse of three cigarettes in June; smoke-free since |
| Home blood pressure | Average 132/84 |

## Review of systems

| System | Result | Finding |
|---|---|---|
| Constitutional | Negative | Rested; more energy |
| Respiratory | Negative | No cough |
| Cardiovascular | Negative | No chest pain or palpitations |
| Psychiatric | Positive | Mood mostly good; still watchful in crowds; no suicidal ideation |

4 systems reviewed. **S**

## Current medications

- Varenicline 1 mg tablet, one by mouth twice daily after food **S**
- Sertraline 50 mg tablet, one by mouth each morning **S**

## Allergies

- No known allergy **S**

## Objective

BP 130/84 mmHg; pulse 72 bpm; respirations 14/min; temperature 36.6 °C; oxygen saturation 98% on room air; weight 84 kg; BMI 29.1 kg/m². All vital signs are synthetic.

PHQ-9: 8; GAD-7: 5; PC-PTSD-5: 1. All results are synthetic.

## Change since baseline

- PHQ-9: 17 at baseline, 8 at this visit **S**
- GAD-7: 11 at baseline, 5 at this visit **S**
- PC-PTSD-5: 2 at baseline, 1 at this visit **S**

## Physical examination

| System | Finding |
|---|---|
| General | Rested; blood pressure 130/84, pulse 72; weight 84.0 kg, BMI 29.1 |
| Cardiovascular | Regular rhythm; no murmur |
| Psychiatric | Euthymic, warm, reactive affect; no suicidal ideation |

All examination findings are synthetic. **S**

## Assessment and plan

1. **Major depressive disorder, responding** (F32.1). PHQ-9 8, a 53 percent fall from 17: response. GAD-7 5. Repeat PC-PTSD-5 1, positive only for being on guard, which fits his real circumstances. **S**
   - Continue sertraline 50 mg; no increase needed.
   - Therapy every two weeks.
   - Safety plan reviewed and unchanged; 988 Suicide & Crisis Lifeline and the clinic number confirmed.
2. **Nicotine dependence, in early remission** (F17.210). Smoke-free apart from one lapse after a threat. A second twelve-week course of varenicline lowers the risk of relapse in people who have quit. **S**
   - Continue varenicline 1 mg twice daily for a further twelve weeks.
   - A plan for threatening calls that does not involve cigarettes, practised in therapy.
3. **Stage 1 hypertension** (I10). Home average 132/84, falling with lifestyle changes and stopping smoking. **S**
   - Continue lifestyle treatment; recheck home readings before the next visit.
4. **Insomnia disorder, improving** (G47.00). Insomnia Severity Index 10; about six and a half hours a night. **S**
   - Keep the fixed rising time while travelling.

## Protocol monitoring

Items the monitoring protocol calls for at this visit. **S**

| Domain | Measure | Interval | Status | Detail |
|---|---|---|---|---|
| Survey | PHQ-9 | At least monthly during acute treatment; every 2 to 4 weeks in continuation | Completed today | 8, a 53 percent fall from 17 |
| Survey | GAD-7 | Every 4 to 8 weeks during treatment | Completed today | 5 |
| Survey | PTSD screen (PC-PTSD-5) | Repeat at about three months and if trauma symptoms emerge | Completed today | 1: on guard only; no PTSD |
| Survey | Suicide risk reassessment (C-SSRS Since Last Visit and PHQ-9 item 9) | Every visit | Completed today | No suicidal ideation; PHQ-9 item 9 scored 0. Safety plan reviewed |
| Referral | Psychiatry follow-up | At about eight to twelve weeks | Completed today | Video review with Dr. Lindqvist-Bankole last month; plan unchanged |
| Medication safety | Adherence and adverse-effect review | Every visit | Completed today | No missed sertraline doses; nausea on varenicline has settled |
| Self-management | Smoking status after the quit date | Every visit | Completed today | One lapse in June; smoke-free since |
| Survey | Insomnia Severity Index and sleep diary | Every visit during CBT for insomnia | Completed today | Insomnia Severity Index 10; about six and a half hours a night (score in the notes; no LOINC code used) |
| Examination | Home blood pressure readings | A week before each visit while treatment is adjusted | Completed today | Seven-day average 132/84 |
| Examination | Office blood pressure, weight and BMI | Every visit | Completed today | 130/84 mmHg; weight 84.0 kg |
| Self-management | Sustainable work plan: a day off each week, two speeches a day at most, sleep window kept | Every visit | Completed today | Day off kept most weeks; two-week break taken |

## Goal progress

- Depression remission (PHQ-9 below 5) by six months. In progress; target 2026-09-15. **S**
- Sleep of at least six and a half hours on most nights, with an Insomnia Severity Index below 10. In progress; target 2026-09-15. **S**
- Smoke-free, confirmed at every visit after the quit date. In progress; target 2026-11-30. **S**
- Home blood pressure below 130/80 mmHg with lifestyle changes. In progress; target 2026-12-31. **S**
- A sustainable schedule: one full day a week without work, no more than two speeches a day, and a two-week break in the summer. Outcome by 2026-07-14: Kept for six weeks; two-week break taken in July. **S**

## Guideline basis

- Clinical Practice Guideline for the Treatment of Depression Across Three Age Cohorts (2019), American Psychological Association
- CMID: Clinical Monitoring Intelligence Database, depression, bipolar, and mood disorders, hypertension and hyperlipidemia monographs (2026), Aether Forge
- VA/DoD Clinical Practice Guideline for the Management of Major Depressive Disorder (2022), United States Department of Veterans Affairs and Department of Defense
- VA/DoD Clinical Practice Guideline for Assessment and Management of Patients at Risk for Suicide (2024), United States Department of Veterans Affairs and Department of Defense
- VA/DoD Clinical Practice Guideline for the Management of Posttraumatic Stress Disorder and Acute Stress Disorder (2023), United States Department of Veterans Affairs and Department of Defense
- Tobacco Smoking Cessation in Adults, Including Pregnant Persons: Interventions (2021), U.S. Preventive Services Task Force
- Neuropsychiatric safety and efficacy of varenicline, bupropion, and nicotine patch in smokers with and without psychiatric disorders (EAGLES) (2016), The Lancet (Anthenelli RM, et al. Lancet 2016;387(10037):2507-2520)
- 2017 ACC/AHA/AAPA/ABC/ACPM/AGS/APhA/ASH/ASPC/NMA/PCNA Guideline for the Prevention, Detection, Evaluation, and Management of High Blood Pressure in Adults (2017), American College of Cardiology and American Heart Association (Whelton PK, et al. Hypertension 2018;71(6):e13-e115)

## Follow-up

- Review in nine weeks with repeat lipids. **S**
- Next scheduled visit 2026-09-15: twenty-three-week review: remission, smoking, blood pressure and lipids. **S**
